ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Associate Director/Director Information Security at Axsome Therapeutics - ApplyBlast

Associate Director/Director Information Security

Axsome Therapeutics

18 days ago

3.1 on Glassdoor

New York, New York, United States

Hybrid

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Axsome Therapeutics is seeking a hands-on leader to direct the cybersecurity team and service providers while actively engaging in technical work. This role executes and advances the corporate Information Security Program, maintaining security posture through threat management, incident response, and vulnerability management. The position requires on-site presence in New York City and involves leading security operations, managing third-party risks, and supporting cloud security governance.

Responsibilities

Lead security monitoring and threat hunting across SIEM and endpoint tools
Direct incident response investigations and lead post-incident reviews
Manage vulnerability management program and third-party risk assessments

Skills

Qualifications

Bachelor's degree in computer science, Information Security, or a related fieldCISSPCISMCISAGIAC (GCIH / GCIA / GCFA)

About Axsome Therapeutics

axsome.com

Headquarters

New York, New York, United States

Company Size

201-500 employees

Founded

2012

View Profile

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Its pipeline and commercial programs include candidates such as AXS-05, AXS-12 and AXS-14, addressing disorders including major depressive disorder, Alzheimer’s disease agitation, migraine, narcolepsy and fibromyalgia. Axsome emphasizes innovative mechanisms of action and rigorous clinical development to deliver meaningful improvements in patient outcomes. The company is headquartered in New York City and advances programs through regulatory engagement and commercialization efforts.